DanBrit acquires Enochian Biopharm to expand its immunotherapy pipeline
CISION PR Newswire - 23-Jan-2018Will rebrand as Enochian and also move to Los Angeles
DanDrit
Cancer vaccines company within immunotherapy - renamed to Enochian BioSciences
DanDrit Biotech USA, Inc. (OTCQB: DDRT) is a development stage, biopharmaceutical company with 15 year history developing immunotherapies for cancer.
Visit website: http://www.dandrit.com/
See also
Enochian BioSciences
Gene-modified cell therapy company focussed on cures for infectious diseases and cancer
Details last updated 13-Jul-2020
DanDrit News
